Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: The tender titled 'Open House Biologika Rabattverträge 2026 - 31 Ranibizumab' is issued by Techniker Krankenkasse, located in Hamburg, Germany. The contract aims to establish discount agreements for the pharmaceutical substance Ranibizumab, with a contract duration of up to 24 months starting from January 1, 2027.
Scope Of Work: The objective is to enter into discount agreements under § 130a Abs. 8 SGB V for the substance Ranibizumab with all suitable pharmaceutical companies. The agreements will not involve individual negotiations on contract terms, and no exclusivity is guaranteed to any partner. The maximum contract duration is 24 months, concluding no later than December 31, 2028.
Qualification Criterion: Eligible bidders must be pharmaceutical companies capable of entering into discount agreements for Ranibizumab. The tender follows an open-house procedure where uniform conditions apply, and individual negotiations are not permitted. Specific details regarding participation and contract documents are available in the tender documents.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |